These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24102313)

  • 1. The potential of acridine carboxamide Pt complexes as anti-cancer agents : a review.
    Murray V; Chen JK; Galea AM
    Anticancer Agents Med Chem; 2014 Jun; 14(5):695-705. PubMed ID: 24102313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin Analogues with an Increased Interaction with DNA: Prospects for Therapy.
    Hardie ME; Kava HW; Murray V
    Curr Pharm Des; 2016; 22(44):6645-6664. PubMed ID: 27587202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells.
    Temple MD; Recabarren P; McFadyen WD; Holmes RJ; Denny WA; Murray V
    Biochim Biophys Acta; 2002 Apr; 1574(3):223-30. PubMed ID: 11997087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG methylation increases the DNA binding of 9-aminoacridine carboxamide Pt analogues.
    Kava HW; Murray V
    Bioorg Med Chem; 2016 Oct; 24(19):4701-4710. PubMed ID: 27567075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sequence selectivity of DNA-targeted 9-aminoacridine cisplatin analogues in a telomere-containing DNA sequence.
    Paul M; Murray V
    J Biol Inorg Chem; 2011 Jun; 16(5):735-43. PubMed ID: 21465324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal-based anticancer chemotherapeutic agents.
    Muhammad N; Guo Z
    Curr Opin Chem Biol; 2014 Apr; 19():144-53. PubMed ID: 24608084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytotoxicity and structure-activity relationships between ester and amide functionalities in novel acridine-based platinum(II) complexes.
    Bouyer F; Moretto J; Pertuit D; Szollosi A; Lacaille-Dubois MA; Blache Y; Chauffert B; Desbois N
    J Inorg Biochem; 2012 May; 110():51-7. PubMed ID: 22459174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives.
    Finlay GJ; Riou JF; Baguley BC
    Eur J Cancer; 1996 Apr; 32A(4):708-14. PubMed ID: 8695277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA binding properties of 9-aminoacridine carboxamide Pt complexes.
    Kava HW; Leung WY; Galea AM; Murray V
    Bioorg Med Chem; 2021 Jun; 40():116191. PubMed ID: 33965841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA minor groove adducts formed by a platinum-acridine conjugate inhibit association of tata-binding protein with its cognate sequence.
    Budiman ME; Bierbach U; Alexander RW
    Biochemistry; 2005 Aug; 44(33):11262-8. PubMed ID: 16101310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment.
    Wang Z; Deng Z; Zhu G
    Dalton Trans; 2019 Feb; 48(8):2536-2544. PubMed ID: 30633263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II).
    Lee HH; Palmer BD; Baguley BC; Chin M; McFadyen WD; Wickham G; Thorsbourne-Palmer D; Wakelin LP; Denny WA
    J Med Chem; 1992 Aug; 35(16):2983-7. PubMed ID: 1501223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Acridines as Antiproliferative Agents.
    Baliwada A; Rajagopal K; Varakumar P; Raman K; Byran G
    Mini Rev Med Chem; 2022; 22(21):2769-2798. PubMed ID: 35546777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acridine as an Anti-Tumour Agent: A Critical Review.
    Varakumar P; Rajagopal K; Aparna B; Raman K; Byran G; Gonçalves Lima CM; Rashid S; Nafady MH; Emran TB; Wybraniec S
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
    Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
    Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers.
    Suryadi J; Bierbach U
    Chemistry; 2012 Oct; 18(41):12926-34. PubMed ID: 22987397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
    Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
    Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterising the atypical 5'-CG DNA sequence specificity of 9-aminoacridine carboxamide Pt complexes.
    Kava HW; Galea AM; Md Jamil F; Feng Y; Murray V
    J Biol Inorg Chem; 2014 Aug; 19(6):997-1007. PubMed ID: 24827388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.
    Jagodinsky JC; Sulima A; Cao Y; Poprawski JE; Blackman BN; Lloyd JR; Swenson RE; Gottesman MM; Hall MD
    J Biol Inorg Chem; 2015 Oct; 20(7):1081-95. PubMed ID: 26323351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.